Distigmine

未知生产厂商

Distigmine is a cholinesterase inhibitor indicated in the treatment of neurogenic bladder dysfunction or myasthenia gravis.

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

Distigmine is a cholinesterase inhibitor indicated in the treatment of neurogenic bladder dysfunction or myasthenia gravis.

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Improved distigmine bromide formulation
EP 2356984 A1申请人: NYCOMED AUSTRIA GMBH优先权: 2010
EP
Solid preparation taking distigmine bromide as active ingredient
CN 103054823 A申请人: BEIJING FUKANGREN BIOPHARMACEUTICAL TECHNOLOGY CO LTD优先权: 2012
CN
Preparation method of high-purity distigmine bromide
CN 107915675 A申请人: BEIJING FUKANGREN BIOPHARMACEUTICAL TECH CO LTD优先权: 2016
CN